Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Lancet (London, England)|July 29, 2014
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialMarc A Rodger, William M Hague, John Kingdom, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarinRoisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
Research and Practice in Thrombosis and Haemostasis|August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarinIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Blood Advances|June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Holger J Schünemann, et al.
The New England Journal of Medicine|April 13, 2026
Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized TrialSuresh Vedantham, Susan R Kahn, William A Marston, et al.
Blood Advances|February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances|September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances|May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patientsAdam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
Pageof 23